tiprankstipranks
Advertisement
Advertisement
Cingulate issued complete response letter for CTx-1301 from FDA
PremiumThe FlyCingulate issued complete response letter for CTx-1301 from FDA
16d ago
Cingulate Faces FDA Delay But Maintains ADHD Drug Plans
Premium
Company Announcements
Cingulate Faces FDA Delay But Maintains ADHD Drug Plans
16d ago
Cingulate Reshapes Board Structure and Leadership Roles
Premium
Company Announcements
Cingulate Reshapes Board Structure and Leadership Roles
29d ago
Cingulate Adds Independent Director Jiang to Board Committees
PremiumCompany AnnouncementsCingulate Adds Independent Director Jiang to Board Committees
3M ago
Cingulate Announces ATM Equity Program and Share Issuance
Premium
Company Announcements
Cingulate Announces ATM Equity Program and Share Issuance
3M ago
Cingulate price target lowered to $14 from $16 at Roth Capital
Premium
The Fly
Cingulate price target lowered to $14 from $16 at Roth Capital
3M ago
Cingulate sees cash runway into late 4Q26
PremiumThe FlyCingulate sees cash runway into late 4Q26
3M ago
CING Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
CING Earnings this Week: How Will it Perform?
4M ago
Cingulate Secures $12 Million PIPE to Advance CTx-1301
Premium
Company Announcements
Cingulate Secures $12 Million PIPE to Advance CTx-1301
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100